Drugs / Paullinia cupana extract PC102
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00144235 | Mar → Jul 2005 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Paullinia cupana extract PC102 | “Paullinia cupana extract PC102 75 mg (Guarana)” NCT00144235 ↗ |
| Known as | Guarana | “Paullinia cupana extract PC102 75 mg (Guarana)” NCT00144235 ↗ |
| Route | Oral | “1/Day p.o.” NCT00144235 ↗ |